Search results
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
Zacks via Yahoo Finance· 7 days agoBoston Scientific Corporation BSX is scheduled to report first-quarter 2024 results on Apr 24,...
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Benzinga via Yahoo Finance· 5 days agoOn Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a...
Boston Sci issues corrective recall for Obsidio Embolic over safety concerns
Seeking Alpha· 6 days agoBoston Scientific (BSX) has issued a corrective recall for its embolization agent Obsidio, warning...
Sumitomo Mitsui DS Asset Management Company Ltd Acquires 6,788 Shares of Boston Scientific Co....
ETF DAILY NEWS· 22 hours agoSumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 4.5% in the 4th quarter, Holdings Channel.com reports. The ...
Signaturefd LLC Has $1.46 Million Holdings in Boston Scientific Co. (NYSE:BSX)
ETF DAILY NEWS· 23 hours agoSignaturefd LLC grew its position in Boston Scientific Co. (NYSE:BSX – Free Report) by 1.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange ...
Lindbrook Capital LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX)
ETF DAILY NEWS· 1 day agoLindbrook Capital LLC lifted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 52.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 16 hours agoNEWARK, Del, April 22, 2024 (GLOBE NEWSWIRE) -- The peripheral vascular stent market value is expected to rise from US$ 4,267.70 million in 2024 to US$ 8,878.00 million by 2034. This market is analyzed to surge ahead at a CAGR of 7.60% over
Royal Bank of Canada Raises Boston Scientific (NYSE:BSX) Price Target to $78.00
ETF DAILY NEWS· 5 days agoBoston Scientific (NYSE:BSX – Free Report) had its price objective hoisted by Royal Bank of Canada from $70.00 to $78.00 in a report issued on Monday, Benzinga reports. Royal Bank of Canada ...
Boston Scientific (BSX) – Analysts’ Weekly Ratings Changes
ETF DAILY NEWS· 4 days ago4/15/2024 – Boston Scientific had its price target raised by analysts at Royal Bank of Canada from $70.00 to $78.00. 4/4/2024 – Boston Scientific had its price target raised by analysts at Evercore ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 hours agoElectroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion, Globally, by 2032 at 7.4% CAGR: Allied Market Research PR Newswire PORTLAND, Ore., April 23, 2024 Increasing prevalence of chronic diseases, advancements in technology, and rising
